The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Antisense Oligonucleotide Therapies Market Research Report 2025
Synopsis
The global Antisense Oligonucleotide Therapies market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Antisense Oligonucleotide Therapies is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Antisense Oligonucleotide Therapies is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Antisense Oligonucleotide Therapies in Genetic Disease is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Antisense Oligonucleotide Therapies include Ionis Pharmaceuticals, Sarepta Therapeutics and Nippon Shinyaku, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Antisense Oligonucleotide Therapies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antisense Oligonucleotide Therapies.
Report Scope
The Antisense Oligonucleotide Therapies market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antisense Oligonucleotide Therapies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antisense Oligonucleotide Therapies companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Ionis Pharmaceuticals
Sarepta Therapeutics
Nippon Shinyaku
Segment by Type
Without GalNAc-conjugated
With GalNAc-conjugated
Segment by Application
Genetic Disease
Cancer
Cardiovascular Diseases
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antisense Oligonucleotide Therapies companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Antisense Oligonucleotide Therapies market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Antisense Oligonucleotide Therapies is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Antisense Oligonucleotide Therapies is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Antisense Oligonucleotide Therapies in Genetic Disease is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Antisense Oligonucleotide Therapies include Ionis Pharmaceuticals, Sarepta Therapeutics and Nippon Shinyaku, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Antisense Oligonucleotide Therapies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antisense Oligonucleotide Therapies.
Report Scope
The Antisense Oligonucleotide Therapies market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antisense Oligonucleotide Therapies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antisense Oligonucleotide Therapies companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Ionis Pharmaceuticals
Sarepta Therapeutics
Nippon Shinyaku
Segment by Type
Without GalNAc-conjugated
With GalNAc-conjugated
Segment by Application
Genetic Disease
Cancer
Cardiovascular Diseases
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antisense Oligonucleotide Therapies companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antisense Oligonucleotide Therapies Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Without GalNAc-conjugated
1.2.3 With GalNAc-conjugated
1.3 Market by Application
1.3.1 Global Antisense Oligonucleotide Therapies Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Genetic Disease
1.3.3 Cancer
1.3.4 Cardiovascular Diseases
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antisense Oligonucleotide Therapies Market Perspective (2019-2030)
2.2 Antisense Oligonucleotide Therapies Growth Trends by Region
2.2.1 Global Antisense Oligonucleotide Therapies Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Antisense Oligonucleotide Therapies Historic Market Size by Region (2019-2024)
2.2.3 Antisense Oligonucleotide Therapies Forecasted Market Size by Region (2025-2030)
2.3 Antisense Oligonucleotide Therapies Market Dynamics
2.3.1 Antisense Oligonucleotide Therapies Industry Trends
2.3.2 Antisense Oligonucleotide Therapies Market Drivers
2.3.3 Antisense Oligonucleotide Therapies Market Challenges
2.3.4 Antisense Oligonucleotide Therapies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antisense Oligonucleotide Therapies Players by Revenue
3.1.1 Global Top Antisense Oligonucleotide Therapies Players by Revenue (2019-2024)
3.1.2 Global Antisense Oligonucleotide Therapies Revenue Market Share by Players (2019-2024)
3.2 Global Antisense Oligonucleotide Therapies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Antisense Oligonucleotide Therapies Revenue
3.4 Global Antisense Oligonucleotide Therapies Market Concentration Ratio
3.4.1 Global Antisense Oligonucleotide Therapies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antisense Oligonucleotide Therapies Revenue in 2023
3.5 Antisense Oligonucleotide Therapies Key Players Head office and Area Served
3.6 Key Players Antisense Oligonucleotide Therapies Product Solution and Service
3.7 Date of Enter into Antisense Oligonucleotide Therapies Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Antisense Oligonucleotide Therapies Breakdown Data by Type
4.1 Global Antisense Oligonucleotide Therapies Historic Market Size by Type (2019-2024)
4.2 Global Antisense Oligonucleotide Therapies Forecasted Market Size by Type (2025-2030)
5 Antisense Oligonucleotide Therapies Breakdown Data by Application
5.1 Global Antisense Oligonucleotide Therapies Historic Market Size by Application (2019-2024)
5.2 Global Antisense Oligonucleotide Therapies Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Antisense Oligonucleotide Therapies Market Size (2019-2030)
6.2 North America Antisense Oligonucleotide Therapies Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Antisense Oligonucleotide Therapies Market Size by Country (2019-2024)
6.4 North America Antisense Oligonucleotide Therapies Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Antisense Oligonucleotide Therapies Market Size (2019-2030)
7.2 Europe Antisense Oligonucleotide Therapies Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Antisense Oligonucleotide Therapies Market Size by Country (2019-2024)
7.4 Europe Antisense Oligonucleotide Therapies Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Antisense Oligonucleotide Therapies Market Size (2019-2030)
8.2 Asia-Pacific Antisense Oligonucleotide Therapies Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Antisense Oligonucleotide Therapies Market Size by Region (2019-2024)
8.4 Asia-Pacific Antisense Oligonucleotide Therapies Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Antisense Oligonucleotide Therapies Market Size (2019-2030)
9.2 Latin America Antisense Oligonucleotide Therapies Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Antisense Oligonucleotide Therapies Market Size by Country (2019-2024)
9.4 Latin America Antisense Oligonucleotide Therapies Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antisense Oligonucleotide Therapies Market Size (2019-2030)
10.2 Middle East & Africa Antisense Oligonucleotide Therapies Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Antisense Oligonucleotide Therapies Market Size by Country (2019-2024)
10.4 Middle East & Africa Antisense Oligonucleotide Therapies Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Ionis Pharmaceuticals
11.1.1 Ionis Pharmaceuticals Company Detail
11.1.2 Ionis Pharmaceuticals Business Overview
11.1.3 Ionis Pharmaceuticals Antisense Oligonucleotide Therapies Introduction
11.1.4 Ionis Pharmaceuticals Revenue in Antisense Oligonucleotide Therapies Business (2019-2024)
11.1.5 Ionis Pharmaceuticals Recent Development
11.2 Sarepta Therapeutics
11.2.1 Sarepta Therapeutics Company Detail
11.2.2 Sarepta Therapeutics Business Overview
11.2.3 Sarepta Therapeutics Antisense Oligonucleotide Therapies Introduction
11.2.4 Sarepta Therapeutics Revenue in Antisense Oligonucleotide Therapies Business (2019-2024)
11.2.5 Sarepta Therapeutics Recent Development
11.3 Nippon Shinyaku
11.3.1 Nippon Shinyaku Company Detail
11.3.2 Nippon Shinyaku Business Overview
11.3.3 Nippon Shinyaku Antisense Oligonucleotide Therapies Introduction
11.3.4 Nippon Shinyaku Revenue in Antisense Oligonucleotide Therapies Business (2019-2024)
11.3.5 Nippon Shinyaku Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Antisense Oligonucleotide Therapies Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Without GalNAc-conjugated
Table 3. Key Players of With GalNAc-conjugated
Table 4. Global Antisense Oligonucleotide Therapies Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Antisense Oligonucleotide Therapies Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Antisense Oligonucleotide Therapies Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Antisense Oligonucleotide Therapies Market Share by Region (2019-2024)
Table 8. Global Antisense Oligonucleotide Therapies Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Antisense Oligonucleotide Therapies Market Share by Region (2025-2030)
Table 10. Antisense Oligonucleotide Therapies Market Trends
Table 11. Antisense Oligonucleotide Therapies Market Drivers
Table 12. Antisense Oligonucleotide Therapies Market Challenges
Table 13. Antisense Oligonucleotide Therapies Market Restraints
Table 14. Global Antisense Oligonucleotide Therapies Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Antisense Oligonucleotide Therapies Market Share by Players (2019-2024)
Table 16. Global Top Antisense Oligonucleotide Therapies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antisense Oligonucleotide Therapies as of 2023)
Table 17. Ranking of Global Top Antisense Oligonucleotide Therapies Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Antisense Oligonucleotide Therapies Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Antisense Oligonucleotide Therapies Product Solution and Service
Table 21. Date of Enter into Antisense Oligonucleotide Therapies Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Antisense Oligonucleotide Therapies Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Antisense Oligonucleotide Therapies Revenue Market Share by Type (2019-2024)
Table 25. Global Antisense Oligonucleotide Therapies Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Antisense Oligonucleotide Therapies Revenue Market Share by Type (2025-2030)
Table 27. Global Antisense Oligonucleotide Therapies Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Antisense Oligonucleotide Therapies Revenue Market Share by Application (2019-2024)
Table 29. Global Antisense Oligonucleotide Therapies Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Antisense Oligonucleotide Therapies Revenue Market Share by Application (2025-2030)
Table 31. North America Antisense Oligonucleotide Therapies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Antisense Oligonucleotide Therapies Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Antisense Oligonucleotide Therapies Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Antisense Oligonucleotide Therapies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Antisense Oligonucleotide Therapies Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Antisense Oligonucleotide Therapies Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Antisense Oligonucleotide Therapies Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Antisense Oligonucleotide Therapies Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Antisense Oligonucleotide Therapies Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Antisense Oligonucleotide Therapies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Antisense Oligonucleotide Therapies Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Antisense Oligonucleotide Therapies Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Antisense Oligonucleotide Therapies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Antisense Oligonucleotide Therapies Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Antisense Oligonucleotide Therapies Market Size by Country (2025-2030) & (US$ Million)
Table 46. Ionis Pharmaceuticals Company Detail
Table 47. Ionis Pharmaceuticals Business Overview
Table 48. Ionis Pharmaceuticals Antisense Oligonucleotide Therapies Product
Table 49. Ionis Pharmaceuticals Revenue in Antisense Oligonucleotide Therapies Business (2019-2024) & (US$ Million)
Table 50. Ionis Pharmaceuticals Recent Development
Table 51. Sarepta Therapeutics Company Detail
Table 52. Sarepta Therapeutics Business Overview
Table 53. Sarepta Therapeutics Antisense Oligonucleotide Therapies Product
Table 54. Sarepta Therapeutics Revenue in Antisense Oligonucleotide Therapies Business (2019-2024) & (US$ Million)
Table 55. Sarepta Therapeutics Recent Development
Table 56. Nippon Shinyaku Company Detail
Table 57. Nippon Shinyaku Business Overview
Table 58. Nippon Shinyaku Antisense Oligonucleotide Therapies Product
Table 59. Nippon Shinyaku Revenue in Antisense Oligonucleotide Therapies Business (2019-2024) & (US$ Million)
Table 60. Nippon Shinyaku Recent Development
Table 61. Research Programs/Design for This Report
Table 62. Key Data Information from Secondary Sources
Table 63. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Antisense Oligonucleotide Therapies Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Antisense Oligonucleotide Therapies Market Share by Type: 2023 VS 2030
Figure 3. Without GalNAc-conjugated Features
Figure 4. With GalNAc-conjugated Features
Figure 5. Global Antisense Oligonucleotide Therapies Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Antisense Oligonucleotide Therapies Market Share by Application: 2023 VS 2030
Figure 7. Genetic Disease Case Studies
Figure 8. Cancer Case Studies
Figure 9. Cardiovascular Diseases Case Studies
Figure 10. Other Case Studies
Figure 11. Antisense Oligonucleotide Therapies Report Years Considered
Figure 12. Global Antisense Oligonucleotide Therapies Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Antisense Oligonucleotide Therapies Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Antisense Oligonucleotide Therapies Market Share by Region: 2023 VS 2030
Figure 15. Global Antisense Oligonucleotide Therapies Market Share by Players in 2023
Figure 16. Global Top Antisense Oligonucleotide Therapies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antisense Oligonucleotide Therapies as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Antisense Oligonucleotide Therapies Revenue in 2023
Figure 18. North America Antisense Oligonucleotide Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Antisense Oligonucleotide Therapies Market Share by Country (2019-2030)
Figure 20. United States Antisense Oligonucleotide Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Antisense Oligonucleotide Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Antisense Oligonucleotide Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Antisense Oligonucleotide Therapies Market Share by Country (2019-2030)
Figure 24. Germany Antisense Oligonucleotide Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Antisense Oligonucleotide Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Antisense Oligonucleotide Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Antisense Oligonucleotide Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Antisense Oligonucleotide Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Antisense Oligonucleotide Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Antisense Oligonucleotide Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Antisense Oligonucleotide Therapies Market Share by Region (2019-2030)
Figure 32. China Antisense Oligonucleotide Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Antisense Oligonucleotide Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Antisense Oligonucleotide Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Antisense Oligonucleotide Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Antisense Oligonucleotide Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Antisense Oligonucleotide Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Antisense Oligonucleotide Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Antisense Oligonucleotide Therapies Market Share by Country (2019-2030)
Figure 40. Mexico Antisense Oligonucleotide Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Antisense Oligonucleotide Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Antisense Oligonucleotide Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Antisense Oligonucleotide Therapies Market Share by Country (2019-2030)
Figure 44. Turkey Antisense Oligonucleotide Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Antisense Oligonucleotide Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Ionis Pharmaceuticals Revenue Growth Rate in Antisense Oligonucleotide Therapies Business (2019-2024)
Figure 47. Sarepta Therapeutics Revenue Growth Rate in Antisense Oligonucleotide Therapies Business (2019-2024)
Figure 48. Nippon Shinyaku Revenue Growth Rate in Antisense Oligonucleotide Therapies Business (2019-2024)
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
